We believe that a longitudinal, Framingham-like study of 100,000 well individuals (hereafter termed the 100K project) and their dynamical data clouds could transform medicine...
Using mass spectrometry methods, the scientists created a predictive model for the disease based on metabolites found in the blood.
New study makes advances in understanding how genetic risk factors alter gene function for schizophrenia.
Thermo Fisher Scientific plans to develop its Oncomine Dx Target Test as a companion diagnostic for Blueprint Medicines' BLU-667.
Company accused of submitting false claims to Medicare for the Decipher prostate cancer test between September 2015 and June 2017
The polymerase chain reaction (PCR) has come a long way during the past three decades to become one of the fundamental platforms in life...
Kintor will use Predicine’s expertise in genomics and molecular information to advance the development of its oncology pipeline
To help identify disease-causing variants in the genome, researchers developed a tool that works by producing artificial “minigenes.”
Partnership designed to offer SOPHiA AI users accurate genomic detection and characterization of tumor alterations in a single test
Genetic diagnostic lab, spun out of Boston Children’s Hospital in 2013, tells the New York State Department of Health that it has shut down.